Dendritic cell function in Vivo during the steady state: A role in peripheral tolerance

Annals of the New York Academy of Sciences

Volumn 987, Issue , 2003, Pages 15-25

  Steinman, Ralph M ^a   Hawiger, Daniel ^a   Liu, Kang ^a   Bonifaz, Laura ^a   Bonnyay, David ^a   Mahnke, Karsten ^a   Iyoda, Tomonori ^b   Ravetch, Jeffrey ^a   Dhodapkar, Madhav ^a   Inaba, Kayo ^b   Nussenzweig, Michel ^b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Antigen presentation; DEC 205; Dendritic cells; Endocytosis; Peripheral tolerance

Indexed keywords

ANTIGEN PRESENTATION; AUTOIMMUNITY; CELL DEATH; CELL FUNCTION; CELL MATURATION; CELLULAR IMMUNITY; CONFERENCE PAPER; GENE SILENCING; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IN VIVO STUDY; INFECTION; INFLAMMATION; MOLECULAR RECOGNITION; NONHUMAN; PHAGOCYTOSIS; REGULATORY MECHANISM; STEADY STATE; SUPPRESSOR CELL; T LYMPHOCYTE; THYMUS;

EID: 0037565445     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb06029.x     Document Type: Conference Paper

References (66)

1. MATZINGER, P. & S. GUERDER. 1989. Does T-cell tolerance require a dedicated antigen-presenting cell? Nature 338: 74-76.
2. ZAL, T., A. VOLKMANN & B. STOCKINGER. 1994. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J. Exp. Med. 180: 2089-2099.
3. VOLKMANN, A., T. ZAL & B. STOCKINGER. 1997. Antigen-presenting cells in thymus that can negatively select MHC class II-restricted T cells recognizing a circulating self antigen. J. Immunol. 158: 693-706.
4. BOUNEAUD, C., P. KOURILSKY & P. BOUSSO. 2000. Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal detection. Immunity 13: 829-840.
5. NOSSAL, G.J.V. 2001. A purgative mastery. Nature 412: 685-686.
6. KEARNEY, E.R., K.A. PAPE, D.Y. LOH, et al. 1994. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1: 327-339.
7. PARIJS, L.V., A. IBRAGHIMOV & A.K. ABBAS. 1996. The roles of costimulation and fas in T cell apoptosis and peripheral tolerance. Immunity 4: 321-328.
8. AICHELE, P., K. BRDUSCHA-RIEM, R.M. ZINKERNAGEL, et al. 1995. T cell priming versus T cell tolerance induced by synthetic peptides. J. Exp. Med. 182: 261-266.
9. DADAGLIO, G., C.A. NELSON, M.B. DECK, et al. 1997. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity 6: 727-738.
10. STEINMAN, R.M. & M.C. NUSSENZWEIG. 2002. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 99: 351-358.
11. HOLT, P.G., S. HAINING, D.J. NELSON, et al. 1994. Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J. Immunol. 153: 256-261.
12. KAMATH, A.T., J. POOLEY, M.A. O'KEEFFE, et al. 2000. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 165: 6762-6770.
13. INABA, K., G. SCHULER, M.D. WITMER, et al. 1986. The immunologic properties of purified Langerhans cells: distinct requirements for the stimulation of unprimed and sensitized T lymphocytes. J. Exp. Med. 164: 605-613.
14. ROMANI, N., S. KOIDE, M. CROWLEY, et al. 1989. Presentation of exogenous protein antigens by dendritic cells to T cell clones: intact protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med. 169: 1169-1178.
15. ROMANI, N., K. INABA, E. PURE, et al. 1989. A small number of anti-CD3 molecules on dendritic cells stimulate DNA synthesis in mouse T lymphocytes. J. Exp. Med. 169: 1153-1168.
16. DHODAPKAR, M., R.M. STEINMAN, M. SAPP, et al. 1999. Rapid generation of broad T-cell immunity in humans after single injection of mature dendritic cells. J. Clin. Invest. 104: 173-180.
17. DHODAPKAR, M.V., J. KRASOVSKY, R.M. STEINMAN, et al. 2000. Mature dendritic cells boost functionally superior T cells in humans without foreign helper epitopes. J. Clin. Invest. 105: R9-R14.
18. SCHULER-THURNER, B., D. DIECKMANN, P. KEIKAVOUSSI, et al. 2000. Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells. J. Immunol. 165: 3492-3496.
19. BANCHEREAU, J., A.K. PALUCKA, M. DHODAPKAR, et al. 2001. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res. 61: 6451-6458.
20. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188: 1359-1368.
21. YRLID, U. & M.J. WICK. 2000. Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells. J. Exp. Med. 191: 613-623.
22. VERMAELEN, K.Y., I. CARRO-MUINO, B.N. LAMBRECHT, et al. 2001. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J. Exp. Med. 193: 51-60.
23. BHARDWAJ, N., J.W. YOUNG, A.J. NISANIAN, et al. 1993. Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses. J. Exp. Med. 178: 633-642.
24. STEINMAN, R.M., S. TURLEY, I. MELLMAN, et al. 2000. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191: 411-416.
25. HAWIGER, D., K. INABA, Y. DORSETT, et al. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194: 769-780.
26. + T cell tolerance. J. Exp. Med. 196: 1627-1638.
27. LIU, K., T. IYODA, M. SATERNUS, et al. 2002. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196: 1091-1097.
28. + regulatory T cells in vivo in humans. Blood 100: 174-177.
29. MENGES, M., S. ROSSNER, C. VOIGTLANDER, et al. 2002. Repetitive injections of dendritic cells matured with tumor necrosis factor α induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195: 15-22.
30. KYEWSKI, B.A., C.G. FATHMAN & R.V. ROUSE. 1986. Intrathymic presentation of circulating non-MHC antigens by medullary dendritic cells. An antigen-dependent microenviroment for T cell differentiation. J. Exp. Med. 163: 231-246.
31. HOLT, P.G., M.A. SCHON-HEGRAD & J. OLIVER. 1987. MHC class II antigen-bearing dendritic cells in pulmonary tissues of the rat. Regulation of antigen presentation activity by endogenous macrophage populations. J. Exp. Med. 167: 262-274.
32. BUJDOSO, R., J. HOPKINS, B.M. DUTIA, et al. 1989. Characterization of sheep afferent lymph dendritic cells and their role in antigen carriage. J. Exp. Med. 170: 1285-1302.
33. LIU, L.M. & G.G. MACPHERSON. 1993. Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo. J. Exp. Med. 177: 1299-1307.
34. CROWLEY, M., K. INABA & R.M. STEINMAN. 1990. Dendritic cells are the principal cells in mouse spleen beating immunogenic fragments of foreign proteins. J. Exp. Med. 172: 383-386.
35. HUANG, F.-P., N. PLATT, M. WYKES, et al. 2000. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191: 435-442.
36. KRAAL, G., M. BREEL, M. JANSE, et al. 1986. Langerhans cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J. Exp. Med. 163: 981-997.
37. SWIGGARD, W.J., A. MIRZA, M.C. NUSSENZWEIG, et al. 1995. DEC-205, a 205 kDa protein abundant on mouse dendritic cells and thymic epithelium that is detected by the monoclonal antibody NLDC-145: purification, characterization and N-terminal amino acid sequence. Cell. Immunol. 165: 302-311.
38. JIANG, W., W.J. SWIGGARD, C. HEUFLER, et al. 1995. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375: 151-155.
39. MAHNKE, K., M. GUO, S. LEE, et al. 2000. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J. Cell Biol. 151: 673-683.
40. CHESNUT, R.W. & H.M. GREY. 1981. Studies on the capacity of B cells to serve as antigen-presenting cells. J. Immunol. 126: 1075-1079.
41. VALLADEAU, J., O. RAVEL, C. DEZUTTER-DAMBUYANT, et al. 2000. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12: 71-81.
42. VALLADEAU, J., V. DUVERT-FRANCES, J.-J. PIN, et al. 2001. Immature human dendritic cells express asialoglycoprotein receptor isoforms for efficient receptor-mediated endocytosis. J. Immunol. 167: 5767-5774.
43. KWON, D.S., G. GREGARIO, N. BITTON, et al. 2002. DC-SIGN mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity 16: 135-144.
44. ENGERING, A., T.B. GEIJTENBEEK, S.J. VAN VLIET, et al. 2002. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol. 168: 2118-2126.
45. DZIONEK, A., Y. SOHMA, J. NAGAFUNE, et al. 2001. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen-capture and is a potent inhibitor of interferon-α/β induction. J. Exp. Med. 194: 1823-1834.
46. + dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195: 1289-1302.
47. SAKAGUCHI, S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101: 455-458.
48. SAOUDI, A., B. SEDDON, V. HEATH, et al. 1996. The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T cell subset. Immunol. Rev. 149: 195-216.
49. JONULEIT, H., E. SCHMITT, M. STASSEN, et al. 2001. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193: 1285-1294.
50. LEVINGS, M.K., R. SANGREGORIO & M.G. RONCAROLO. 2001. Human CD25(+) CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193: 1295-1302.
51. DIECKMANN, D., H. PLOTTNER, S. BERCHTOLD, et al. 2001. Ex vivo isolation and characterization of CD4(+) CD25(+) T cells with regulatory properties from human blood. J. Exp. Med. 193: 1303-1310.
52. NG, W.F., P.J. DUGGAN, F. PONCHEL, et al. 2001. Human CD4(+) CD25(+) cells: a naturally occurring population of regulatory T cells. Blood 98: 2736-2744.
53. + immunoregulatory T cells. J. Exp. Med. 194: 427-438.
54. BACCHETTA, R., M. BIGLER, J.-L. TOURAINE, et al. 1994. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J. Exp. Med. 179: 493-502.
55. RONCAROLO, M.G., R. BACCHETTA, C. BORDIGNON, et al. 2001. Type 1 T regulatory cells. Immunol. Rev. 182: 68-79.
56. JONULEIT, H., E. SCHMITT, G. SCHULER, et al. 2000. Induction of human IL-10-producing, non-proliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature dendritic cells. J. Exp. Med. 192: 1213-1222.
57. DHODAPKAR, M.V., R.M. STEINMAN, J. KRASOVSKY, et al. 2001. Antigen specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193: 233-238.
58. AKBARI, O., R.H. DEKRUYFF & D.T. UMETSU. 2001. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2: 725-731.
59. LEVINGS, M.K., R. SANGREGORIO, F. GALBIATI, et al. 2001. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166: 5530-5539.
60. BLANCO, P., A.K. PALUCKA, M. GILL, et al. 2001. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 294: 1540-1543.
61. MEHLING, A., K. LOSER, G. VARGA, et al. 2001. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J. Exp. Med. 194: 615-628.
62. MOLL, H., H. FUCHS, C. BLANK, et al. 1993. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur. J. Immunol. 23: 1595-1601.
63. VON STEBUT, E., Y. BELKAID, T. JAKOB, et al. 1998. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J. Exp. Med. 188: 1547-1552.
64. HOWARD, J.G., C. HALE & F.Y. LIEW. 1980. Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica. J. Exp. Med. 152: 594-607.
65. LIEW, F.Y., A. SINGLETON, E. CILLARI, et al. 1985. Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection. J. Immunol. 135: 2102-2107.
66. DHODAPKAR, M.V., J. KRASOVSKY & K. OLSON. 2002. T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells. Proc. Natl. Acad. Sci. USA 99: 13009-13013.